Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy

Brain

Volumn 125, Issue 1, 2002, Pages 22-31

  Sisodiya, S M ^a   Lin, W R ^a   Harding, B N ^b   Squier, M V ^c   Thom, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

DNT; Focal cortical dysplasia; Hippocampal sclerosis; MDR1 P glycoprotein; MRP1; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN 1;

ANTICONVULSANT THERAPY; ARTICLE; ASTROCYTE; CORTICAL DYSPLASIA; EPILEPSY; EPILEPTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEUROEPITHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFRACTORY PERIOD; TREATMENT FAILURE;

EID: 0036156280     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf002     Document Type: Article

References (45)

1. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy
2. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations
3. A family of drug transporters: The multidrug resistance-associated proteins
4. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
5. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
6. Dysembryoplastic neuroepithelial tumours
7. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia
8. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies
9. Tissue distribution of the multidrug resistance protein
10. Immunocytochemical studies in epileptogenic dysplastic tissue
11. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea in human glioma cells
12. Biochemical correlates to cortical dysplasia, gliosis, and astrocytoma infiltration in human epileptogenic cortex
13. Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
14. Structural, mechanistic and clinical aspects of MRP1
15. Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. Localization of their epitopes to the nucleotide-binding domains of the protein
16. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
17. Detection of P-glycoprotein in frozen and paraffin-embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies
18. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
19. Multidrug resistance: Molecular mechanisms and clinical relevance
20. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: Cautions on evaluating p170(mdr-1)
21. Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles
22. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells
23. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase
24. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
25. Some aspects of prognosis in the epilepsies: A review
26. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies
27. P-Glycoprotein, a gatekeeper in the blood-brain barrier
28. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
29. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates
30. Is the underlying cause of epilepsy a major prognostic factor for recurrence?
31. Over-expression of P-glycoprotein in malformations of cortical development
32. Multidrug-resistance protein 1 in focal cortical dysplasia
33. Multidrug resistance in haematological malignancies
34. Multidrug resistance transporters and modulation
35. MDR1 gene expression in brain of patients with medically intractable epilepsy
36. Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein
37. Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1
38. Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1)
39. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
40. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies
41. Reversible MRI abnormalities following seizures
42. Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia